Loren Data's SAM Daily™

FBO DAILY ISSUE OF MARCH 03, 2007 FBO #1923
SOLICITATION NOTICE

65 -- Notice of Intent to Procure Vaccinia Immune Globulin Intravenous (VIGIV) on a Sole Source Basis

Notice Date

3/1/2007
 

Notice Type

Solicitation Notice
 

Contracting Office

US Army Space and Missile Defense Command, Deputy Commander, ATTN SMDC-CM-AP, P.O. Box 1500, Huntsville, AL 35807-3801
 

ZIP Code

35807-3801
 

Solicitation Number

W9113M-07-R-SS01
 

Response Due

3/27/2007
 

Archive Date

5/26/2007
 

Small Business Set-Aside

N/A
 

Description

The U.S. Army Space and Missile Defense Command on behalf of the Joint Vaccine Acquisition Program intends to procure on a sole source basis a commercial, FDA-licensed Vaccinia Immune Globulin Intravenous (VIGIV) to treat severe reactions to smallpox vaccinations. The intended source is Cangene Corporation, 104 Chancellor Matheson Road, Winnipeg, Manitoba, Canada. It is anticipated a contract will be issued for a one year base period for ordering product and 6 options periods to procure additional p roduct as required, for a maximum possible total of seven years. This contract will be issued using other than full and open competition procedures in accordance with FAR 6.302-1 and 10 U.S.C. 2304(c)(1), only one responsible source and no other supplies or services will satisfy agency requirements. Cangene Corporation is the only known FDA license holder for VIGIV which currently has the manufacturing capability to maintain the Department of Defense's (DoD's) requirement for a stockpile of 300-1,200 Troo p Equivalent Doses (TEDs). DoD will require contractor to collect source plasma, complete production of final FDA-approved VIGIV, store and distribute DoD stockpile, and provide all materials and documentation required to meet FDA Post-Marketing Commitment s. This is not a request for competitive proposals but parties purporting to have the requisite credentials to furnish these supplies must provide in writing, factual information which clearly supports and demonstrates that their VIGIV product is FDA appr oved, has an existing approved manufacturing facility, as well as the capability to maintain their manufacturing facility and FDA license so the DoD will have a continuous stockpile of licensed VIGIV. This information MUST be emailed to leo.fratis@amedd.a rmy.mil or faxed to his attention at (301)619-7421 by no later than 4:00 p.m. on 27 March 2007. A determination not to compete this proposed action based on any response to this notice is solely within the discretion of the contracting officer.
 

Place of Performance

Address: US Army Space and Missile Defense Command, Deputy Commander ATTN SMDC-CM-AP, P.O. Box 1500 Huntsville AL

Zip Code: 35807-3801

Country: US
 

Record

SN01241914-W 20070303/070301221533 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |